上 市 公 司 美容护理 2025 年 08 月 26 日 珀莱雅 (603605) ——业绩符合预期，多品牌&多品类增长逻辑再强化 报告原因：有业绩公布需要点评 买入（维持） | 市场数据： | 2025 年 08 月 26 日 | | --- | --- | | 收盘价（元） | 91.99 | | 一年内最高/最低（元） | 121.10/73.73 | | 市净率 | 6.3 | | 股息率%（分红/股价） | 1.29 | | 流通 A 股市值（百万元） | 36,373 | | 上证指数/深证成指 | 3,868.38/12,473.17 | | 注："股息率"以最近一年已公布分红计算 | | | 基础数据: | 2025 年 06 月 30 日 | | --- | --- | | 每股净资产（元） | 14.33 | | 资产负债率% | 29.55 | | 总股本/流通 A 股（百万） | 396/395 | | 流通 B 股/H 股（百万） | -/- | 一年内股价与大盘对比走势： 08-26 09-26 10-26 11-26 12-26 01-26 02-26 03-26 04-26 ...

2025 年 08 月 25 日 利润显著修复，终端开瓶向好 买入(维持) 事件 | 分析师：孙山山 | S1050521110005 | | --- | --- | | sunss@cfsc.com.cn | | | 联系人：张倩 | S1050124070037 | | zhangqian@cfsc.com.cn | | | 基本数据 | 2025-08-22 | | --- | --- | | 当前股价（元） | 60.91 | | 总市值（亿元） | 203 | | 总股本（百万股） | 333 | | 流通股本（百万股） | 333 | | 52 周价格范围（元） | 40.18-82.9 | | 日均成交额（百万元） | 637.75 | 市场表现 -20 0 20 40 60 80 100 (%) 舍得酒业 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《舍得酒业（600702）：业绩表 现承压，期待弹性恢复》2025-05- 07 2、《舍得酒业（600702）：业绩短 期承压，期待企稳回升》2025-03- 24 3、《舍得酒业（600702）：调整期 业绩承压，发布回购方案彰 ...

纺织服饰 赢家时尚（03709.HK） 买入-B(维持) 公司近一年市场表现 资料来源：最闻，山西证券研究所 市场数据：2025 年 8 月 22 日 收盘价（港元）： 7.340 | 年内最高/最低（港 | 10.060/6.560 | | --- | --- | | 元）： | | | 流通/总股本（亿股）： | 7.04/7.04 | | 流通市值（亿港元）： | 51.68 | | 总市值（亿港元）： | 51.68 | 王冯 执业登记编码：S0760522030003 邮箱：wangfeng@sxzq.com 孙萌 执业登记编码：S0760523050001 邮箱：sunmeng@sxzq.com 请务必阅读最后股票评级说明和免责声明 1 2025H1 业绩稳健增长，电商渠道表现领先 事件描述 8 月 22 日，公司发布 2025 年上半年业绩。2025H1，公司实现营收 31.04 亿元，同比下降 6.12%；实现归母净利润 2.88 亿元，同比增长 3.19%。 事件点评 2025 年上半年营业收入同比下滑，但业绩端因费用控制实现增长。营收 端，2025H1，公司实现营收 31.04 亿元，同比 ...

图片由AI生成 CXO赛道加速分化的2025上半场，奥浦迈递上一份"高增带忧"的期中答卷。 奥浦迈最新发布的财报显示，公司上半年实现营业收入1.78亿元，同比增长23.77%，培养基主业持续大增。归母净利润3754.69万元，同比大增55.55%；扣 非净利润为2957.73万元，同比飙升76.73%，这种爆发力在二季度集中释放。 毛利率连降、净利率反升的罕见组合，让奥浦迈的成绩单呈现出另一个切面——CDMO板块成本高企，上半年再亏1058.67万元，亏损额虽环比收窄，盈亏 拐点到来仍无明确时点。 费用"瘦身"利润增速反超营收 这份期中答卷的最大亮点，莫过于利润增速对营收增速的反超，其背后是整个CXO行业逐渐走出低谷、加速回暖的清晰信号。 奥浦迈净利润增长曲线，图源：同花顺 一是第二季度的爆发式增长。奥浦迈单季度营收9406.92万元，同比增速达47.21%，归母净利润2287.89万元，同比激增401.78%，扣非净利润更是激增 3012.71%至1877.76万元。随着业务规模扩大，公司边际成本正在快速下降。 营业收入的核心动力主要源于客户管线的持续推进与海外市场的加速扩张。 其中，细胞培养基产品销售收入 ...

上半年，顺应新的行业环境和政策监管要求，本集团积极挖掘渠道协同和衍生服务的业务增长动能，进 一步树立价值驱动理念，加强盈利能力和现金回款等核心业务指标考核，各主要板块业务收入的同比增 速呈现差异化表现。其中，医药分销板块基本维持稳定发展，板块收入占比同比下降0.48个百分点，达 到73.62%;器械分销收入规模有所下降，板块收入占比同比略升0.08个百分点，达到19.22%;医药零售板 块呈现逆势增长态势，板块收入占比同比增长0.36个百分点，为5.78%。 2025年上半年，面对快速变化的政策和市场环境，本集团在董事会和管理层坚实领导下，在加强合规管 理及合理管控风险的同时，聚焦业务的稳定复苏，持续改善各项经营指标，着力打造新环境下业务可持 续发展的能力。 报告期内，本集团费用管控成效凸显，受益于融资成本降低、一体化管控举措和业务成本的下降，销售 费用率、管理费用率及财务费用率持续下降，分别为2.74%、1.28%和0.35%，三项费用率合计优化0.2个 百分点，为收窄利润下降提供有力支撑。 国药控股(01099)发布2025年中期业绩，该集团取得收入人民币2860.43亿元(单位下同)，同比减少2.95% ...

Investment Rating - The report maintains a "Buy" rating for the company, with an expectation of over 20% relative return within the next six months [6][15]. Core Insights - The company reported a revenue of RMB 97.543 billion for the first half of 2025, an increase of RMB 4.621 billion or 4.97% year-on-year. However, the profit before tax decreased by RMB 5.12 billion or 7.06% to RMB 6.737 billion, and the profit attributable to shareholders fell by RMB 1.44 billion or 4.36% to RMB 3.161 billion. The interim dividend was set at RMB 0.166 per share, slightly up from RMB 0.164 per share in the same period last year [1]. Sales Performance - The total natural gas sales volume reached 29.095 billion cubic meters, reflecting a year-on-year growth of 10.05%. Retail gas volume was 16.666 billion cubic meters, up 2.23%. The breakdown shows industrial gas volume at 12.47 billion cubic meters (+8%), commercial gas at 1.693 billion cubic meters (-1.5%), residential gas at 2.014 billion cubic meters (-3.6%), and gas station sales at 0.488 billion cubic meters (-48.5%). Distribution and trade saw a significant increase of 22.6% to 12.429 billion cubic meters. The average sales price of natural gas was RMB 2.77 per cubic meter, down RMB 0.1 from the previous year [2]. Processing and Transportation Performance - The LNG processing and transportation segment generated revenue of RMB 4.371 billion, a slight decrease of 1.58%. However, profit before tax increased by 11.41% to RMB 1.836 billion. The LNG plants achieved a record profit of RMB 140 million, with a 25% reduction in maintenance cycles. The total LNG gasification and loading volume at the receiving stations reached 7.899 billion cubic meters, a year-on-year increase of 1.66% [3]. Oil and LPG Sales - The average selling price of crude oil decreased from USD 67.77 per barrel to USD 62.88 per barrel, leading to a 15.91% drop in crude oil sales revenue to RMB 0.74 billion. LPG sales volume increased by 4.87% to 3.0684 million tons, with revenue rising by 1.03% to RMB 13.02 billion. The profit before tax for the LPG segment decreased by 3.03% to RMB 544 million [4]. Cost Management and Capital Expenditure - The company effectively controlled costs, reducing other sales, general, and administrative expenses to approximately RMB 1.121 billion, down 8.86% from RMB 1.230 billion in the previous year. Employee compensation costs also decreased by 10.07% to approximately RMB 2.850 billion. Capital expenditure for the first half of 2025 was RMB 1.926 billion, a significant decline of 31.6% [5]. Profit Forecast and Valuation - Due to a slowdown in natural gas demand growth and a decline in international oil prices, the profit forecasts for 2025, 2026, and 2027 have been revised down to RMB 6.229 billion, RMB 6.696 billion, and RMB 7.213 billion, respectively, from previous estimates of RMB 6.414 billion, RMB 7.011 billion, and RMB 7.656 billion [6].

Core Viewpoint - The performance of Huaxi Nonferrous (600301) meets expectations, with a focus on the resonance of antimony and tin prices, leading to a "Buy" rating from Guojin Securities analysts Wang Qinyang and Jin Yuntao [1] Financial Performance - For H1 2025, the company achieved a revenue of 2.787 billion yuan, a year-on-year increase of 23.66%, and a net profit attributable to shareholders of 382 million yuan, up 9.49% year-on-year [2] - In Q2 2025, revenue reached 1.543 billion yuan, a quarter-on-quarter increase of 23.95% and a year-on-year increase of 19.55%; net profit was 228 million yuan, up 48.87% quarter-on-quarter and 2.22% year-on-year [2] Price Trends and Sales - In Q2 2025, the prices of the company's main products (antimony, tin, lead, and zinc) changed as follows: antimony +42.98%, tin +3.75%, lead -1.36%, zinc -5.90% quarter-on-quarter; and antimony +86.08%, tin +1.58%, lead -5.89%, zinc -2.96% year-on-year [3] - Sales volumes for lead-antimony concentrate, tin ingots, and zinc ingots changed quarter-on-quarter by +3.98%, +13.01%, and -10.40% respectively [3] Profitability and Cost Management - The company's gross profit and gross margin in Q2 2025 increased by 32.57% and 6.97 percentage points quarter-on-quarter, and by 11.58% and decreased by 6.71 percentage points year-on-year, respectively [3] - The company maintained excellent cost control, with Q2 2025 period expenses at 102 million yuan, a quarter-on-quarter increase of 3.03% and flat year-on-year [4] - The asset-liability ratio at the end of Q2 2025 was 35.84%, showing a continuous optimization of the capital structure [4] Growth Initiatives - As a core listed platform under the Guangxi State-owned Assets Supervision and Administration Commission, the company is actively implementing a three-year action plan, including projects to increase mining capacity from 330,000 tons/year to 450,000 tons/year [4] - The company is also advancing the development of tin-zinc mineral resources in the Tongkuang mining area, with production capacity expanded to 3.5 million tons/year [4] Price Outlook - Antimony prices are expected to rise due to a recovery in exports and approaching demand inflection points, while tin prices are also anticipated to increase due to limited production recovery and strong inventory support [4] Earnings Forecast and Valuation - The company is projected to achieve revenues of 5.7 billion yuan, 6.8 billion yuan, and 7.5 billion yuan for 2025, 2026, and 2027 respectively, with net profits of 980 million yuan, 1.58 billion yuan, and 1.86 billion yuan [5] - The estimated earnings per share (EPS) for the same years are 1.54 yuan, 2.50 yuan, and 2.95 yuan, corresponding to price-to-earnings (PE) ratios of 17, 10, and 9 times [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's Q2 performance showed significant improvement compared to Q1, with a stable operational outlook. Despite a year-on-year decline in revenue and net profit for the first half of 2025, the second quarter saw a quarter-on-quarter revenue increase of 32.14% and a net profit increase of 38.36% [1] - The company is adjusting its profit forecasts due to weak terminal consumer demand and intensified competition in the industry. The expected net profits for 2025-2027 are projected at 0.852 billion, 1.148 billion, and 1.165 billion respectively, with corresponding PE ratios of 20.6, 15.3, and 15.1 times [1] - The company is expected to benefit from economic stabilization policies and a recovering real estate market, which will enhance its brand advantage and performance growth [1] Revenue and Profitability - In H1 2025, the company achieved total revenue of 2.078 billion, a year-on-year decrease of 11.33%, and a net profit of 0.271 billion, down 20.25% year-on-year. The Q2 revenue was 1.183 billion, a year-on-year decrease of 12.16% but a quarter-on-quarter increase of 32.14% [1][2] - The company's core products, including PPR, PE, and PVC series, reported revenues of 0.933 billion, 0.411 billion, and 0.290 billion respectively, with year-on-year growth rates of -13.04%, -13.28%, and -4.21% [2] - The overall gross margin for H1 2025 was 40.50%, a decrease of 1.61 percentage points year-on-year, with specific margins for PPR, PE, and PVC products at 57.53%, 26.91%, and 23.54% respectively [2] Cost Management and Cash Flow - The company's expense ratio increased slightly to 24.99% in H1 2025, with sales, management, R&D, and financial expense ratios at 15.05%, 6.98%, 3.37%, and -0.40% respectively [3] - Operating cash flow for H1 2025 was 0.581 billion, a significant year-on-year increase of 99.10%, primarily due to reduced raw material purchases [3] Strategic Initiatives - The company is focusing on enhancing brand value and competitive advantages by expanding its marketing network and controlling unnecessary expenditures to improve efficiency [4] - It has established over 50 sales companies and more than 30,000 marketing outlets, aiming to strengthen customer loyalty and explore overseas growth opportunities [4]

Core Viewpoint - The company, Yanjing Beer, reported strong financial performance in the first half of 2025, with significant growth in both revenue and net profit, indicating effective product and market strategies [3][4]. Financial Performance - In H1 2025, Yanjing Beer achieved operating revenue of 8.56 billion yuan, a year-on-year increase of 6.4%, and a net profit attributable to shareholders of 1.1 billion yuan, up 45.4% year-on-year [3]. - In Q2 2025, the company recorded operating revenue of 4.73 billion yuan, a 6.1% increase year-on-year, and a net profit of 940 million yuan, reflecting a 43% year-on-year growth [3]. Sales and Product Structure - The beer revenue in H1 2025 was 7.896 billion yuan, with a 6.9% year-on-year increase, driven by a 2.0% increase in beer sales volume to 2.3517 million kiloliters and a 4.8% increase in average selling price to approximately 3,358 yuan per kiloliter [4]. - The revenue from mid-to-high-end products reached 5.536 billion yuan, a 9.3% increase year-on-year, while ordinary products generated 2.36 billion yuan, up 1.6% [4]. - Non-beer business also saw rapid growth, with natural water and beverage revenues of 9.41 million yuan and 83.01 million yuan, respectively, marking year-on-year increases of 21.1% and 98.7% [4]. Cost Management and Profitability - The gross profit margins for H1 2025 and Q2 2025 were 45.5% and 47.7%, respectively, with year-on-year changes of +2.14 and -0.63 percentage points [5]. - The sales expense ratio decreased to 10.33% in H1 2025 and 6.02% in Q2 2025, reflecting a reduction in advertising expenses [5]. - The net profit margin for H1 2025 reached 14.83%, an increase of 3.99 percentage points year-on-year, while Q2 2025 saw a net profit margin of 22.03%, up 5.37 percentage points [5]. Market Expansion Strategies - The company is focusing on expanding its U8 product line and enhancing its competitive edge through increased R&D investment and promotion of canned products [6]. - Yanjing Beer is implementing a comprehensive channel strategy, strengthening offline distribution and expanding online retail channels [6]. - The beverage segment is being developed with the launch of the Beiste soft drink, aimed at leveraging synergies with the beer business [7].

Group 1 - The company reported Q2 performance slightly exceeding expectations, with revenue of 90.9 billion yuan, a year-on-year decrease of 6.4%, and a net profit attributable to shareholders of 6.12 billion yuan, down 25.1% year-on-year [1] - Despite growth in sales volume across polyurethane, petrochemicals, fine chemicals, and new materials, the overall revenue declined due to falling sales prices, while the gross profit margin decreased from 16.41% to 13.84% year-on-year [1] - Cost control measures were crucial in mitigating the decline in gross profit, with Q2 gross profit at 5.82 billion yuan, a decrease of 9.5 billion yuan from Q1, but net profit remained stable due to effective expense management [1] Group 2 - The company aims to shift its management approach towards a performance-oriented mindset in 2025, which is expected to help reverse the current downward trend in performance amid a challenging global macroeconomic environment [2] - The company forecasts earnings per share (EPS) of 4.38, 5.25, and 6.41 yuan for 2025-2027, with a target price of 96.36 yuan based on a 22 times price-to-earnings (PE) ratio for 2025, maintaining a buy rating [2] - The anticipated recovery in MDI and TDI products is expected to benefit from a favorable industry landscape, potentially improving market sentiment towards the company [2]